Agrenvec
Agrenvec is a European biotech specialized in plant production of mammalian recombinant proteins and antibodies for the R&D market.
Agrenvec operates in biotechnology, manufacturing based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2002.
The company sits in the biotechnology, manufacturing segment, where it competes on its core product or service.
Its base of operations is European Union (EU), Europe, Middle East, and Africa (EMEA).
Its current recorded stage is Private company.
The company reports a headcount in the c_00011_00050 range.
| Sector | Biotechnology, Manufacturing |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2002 |
| Employees | c_00011_00050 |
| Stage | Private company |
Website: www.agrenvec.es
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account